Jefferies sees Arbutus (ABUS) potentially benefitting from vaccines being developed by Moderna (MRNA) and Pfizer (PFE)/GSK ...

2024年10月8日，杜克大学Nicholas S Heaton携手mRNA诺奖得主Drew Weissman在《Nature Communications》杂志上发表题为“Improved influenza vaccine responses ...